ARISE: After 8 Hours Reperfusion in Ischemic Stroke Embolization (ARISE)
Sponsor: Abington Memorial Hospital
Suspended
Similar large international competing trial with results of strong positive statistically benefit
Listed as NCT02533778, this NA trial focuses on Ischemic Stroke and remains suspended. Sponsored by Abington Memorial Hospital, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
-
Dec 2021 — Jul 2024 [monthly]
Suspended NA
-
Jan 2021 — Dec 2021 [monthly]
Suspended NA
-
Nov 2020 — Jan 2021 [monthly]
Suspended NA
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Suspended NA
-
May 2018 — Jun 2018 [monthly]
Suspended NA
-
Aug 2017 — May 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended · Phase: EARLY_PHASE1 → NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Jul 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abington Memorial Hospital
For direct contact, visit the study record on ClinicalTrials.gov .